Correlation Between Acurx Pharmaceuticals and MediciNova

Can any of the company-specific risk be diversified away by investing in both Acurx Pharmaceuticals and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acurx Pharmaceuticals and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acurx Pharmaceuticals LLC and MediciNova, you can compare the effects of market volatilities on Acurx Pharmaceuticals and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acurx Pharmaceuticals with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acurx Pharmaceuticals and MediciNova.

Diversification Opportunities for Acurx Pharmaceuticals and MediciNova

-0.66

Correlation Coefficient

Acurx Pharmaceuticals  MediciNova

Excellent diversification

The 3 months correlation between Acurx and MediciNova is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Acurx Pharmaceuticals LLC and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Acurx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acurx Pharmaceuticals LLC are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Acurx Pharmaceuticals i.e., Acurx Pharmaceuticals and MediciNova go up and down completely randomly.

Pair Corralation between Acurx Pharmaceuticals and MediciNova

Given the investment horizon of 90 days Acurx Pharmaceuticals LLC is expected to under-perform the MediciNova. But the stock apears to be less risky and, when comparing its historical volatility, Acurx Pharmaceuticals LLC is 1.4 times less risky than MediciNova. The stock trades about -0.21 of its potential returns per unit of risk. The MediciNova is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  180.00  in MediciNova on September 15, 2024 and sell it today you would earn a total of  34.00  from holding MediciNova or generate 18.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Acurx Pharmaceuticals LLC  vs.  MediciNova

Acurx Pharmaceuticals LLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acurx Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

MediciNova

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Acurx Pharmaceuticals and MediciNova

The main advantage of trading using opposite Acurx Pharmaceuticals and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acurx Pharmaceuticals position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.

The idea behind Acurx Pharmaceuticals LLC and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.